KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Clover Health Investments (CLOV) Operating Leases (2020 - 2024)

Clover Health Investments (CLOV) has disclosed Operating Leases for 5 consecutive years, with $2.3 million as the latest value for Q3 2024.

  • For the quarter ending Q3 2024, Operating Leases fell 29.5% year-over-year to $2.3 million, compared with a TTM value of $2.3 million through Sep 2024, down 29.5%, and an annual FY2023 reading of $3.0 million, down 25.66% over the prior year.
  • Operating Leases was $2.3 million for Q3 2024 at Clover Health Investments, down from $2.5 million in the prior quarter.
  • Across five years, Operating Leases topped out at $6.3 million in Q4 2020 and bottomed at $2.3 million in Q3 2024.
  • Average Operating Leases over 5 years is $4.0 million, with a median of $4.0 million recorded in 2022.
  • The sharpest move saw Operating Leases decreased 6.97% in 2022, then tumbled 30.48% in 2024.
  • Year by year, Operating Leases stood at $6.3 million in 2020, then dropped by 23.93% to $4.8 million in 2021, then decreased by 16.5% to $4.0 million in 2022, then fell by 25.66% to $3.0 million in 2023, then fell by 22.58% to $2.3 million in 2024.
  • Business Quant data shows Operating Leases for CLOV at $2.3 million in Q3 2024, $2.5 million in Q2 2024, and $2.7 million in Q1 2024.